(Q52865237)

9 May 2018

title

Expression of cytokeratin 20 redefines urothelial papillomas of the bladder. (English)

1 reference

9 May 2018

author

Jennifer Southgate

series ordinal

3

1 reference

9 May 2018

author name string

P Harnden

series ordinal

1

1 reference

9 May 2018

N Mahmood

series ordinal

2

1 reference

9 May 2018

language of work or name

English

0 references

publication date

1 March 1999

1 reference

9 May 2018

published in

The Lancet

1 reference

9 May 2018

volume

353

1 reference

9 May 2018

page(s)

974-977

1 reference

9 May 2018

issue

9157

1 reference

9 May 2018

Transitional cell neoplasms of the urinary bladder. Can biologic potential be predicted from histologic grading?

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2905383-5

7 January 2021

Bladder cancer incidence and survival in the south-eastern part of the Netherlands, 1975–1989

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2905383-5

7 January 2021

Cytokeratin 20 as an objective marker of urothelial dysplasia.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2905383-5

7 January 2021

Cytokeratin 20 expression by non-invasive transitional cell carcinomas: potential for distinguishing recurrent from non-recurrent disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2905383-5

7 January 2021

Proposal for changes in cystoscopic follow up of patients with bladder cancer and adjuvant intravesical chemotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2905383-5

7 January 2021

The application of a prognostic factor analysis for Ta.T1 bladder cancer in routine urological practice

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2905383-5

7 January 2021

Factors affecting recurrence and progression in superficial bladder tumours.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2905383-5

7 January 2021

The biological behavior of transitional cell papilloma of the bladder

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2905383-5

7 January 2021

Benign Papilloma or Papillary Carcinoma of the Bladder?

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2905383-5

7 January 2021

Treated history of noninvasive grade 1 transitional cell carcinoma. The National Bladder Cancer Group

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2905383-5

7 January 2021

Analysis of the performance of pathologists in the grading of bladder tumors.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2905383-5

7 January 2021

10.1016/S0140-6736(98)05383-5

Identifiers

DOI

1 reference

9 May 2018

PubMed ID

10459907

1 reference

9 May 2018